D. Sommerhalder

Statistics

Publications

Citations

115

H-Index

Active since

2023

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

D. Sommerhalder is an author at The University of Texas MD Anderson Cancer Center specializing in ras-targeted therapies, pancreatic cancer pharmacotherapy, and non-small cell lung cancer therapy.

Publications per year

2023–2023

Publications

652O Preliminary clinical activity of RMC-6236, a first-in-class, RAS-selective, tri-complex RAS-MULTI(ON) inhibitor in patients with KRAS mutant pancreatic ductal adenocarcinoma (PDAC) and non-small cell lung cancer (NSCLC)

Kathryn C. Arbour, Salman R. Punekar, Ignacio Garrido‐Laguna et al. · Annals of Oncology · 2023 · 115 citations · Full text

Medicine, Oncology, Pharmacology +15

1–1 of 1